Alumis (ALMS) Asset Utilization Ratio (2025 - 2026)
Alumis (ALMS) posted quarterly Asset Utilization Ratio of 0.05 for Q4 2025.
Alumis (ALMS) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Alumis (ALMS) has reported Asset Utilization Ratio for 1 consecutive years, with 0.05 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.05; the TTM figure through Dec 2025 stood at 0.05 (changed N/A YoY), while the FY2025 annual figure was 0.06, changed N/A from the prior year.
- Asset Utilization Ratio steadied at 0.05 in Q4 2025 per ALMS's latest filing.
- Across five years, Asset Utilization Ratio topped out at 0.05 in Q4 2025 and bottomed at 0.05 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.32 Bn | 132.47 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.35 Bn | 58.16 Bn | 1.37 Bn | - |
| 4 | Moderna | 63.15 Bn | 58.01 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.96 Bn | 36.86 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 0.90 |
| 7 | Royalty Pharma | 27.67 Bn | 26.83 Bn | - | 0.13 |
| 8 | BioNTech SE | 27.52 Bn | 9.13 Bn | 668.28 Mn | 0.13 |
| 9 | Insmed | 26.98 Bn | 25.82 Bn | 358.27 Mn | 0.54 |
| 10 | Alumis | 3.06 Bn | 2.56 Bn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Dec 31, 2025 | 0.05 |